Haleon plc (NYSE:HLN) Shares Purchased by WCM Investment Management LLC

WCM Investment Management LLC increased its holdings in Haleon plc (NYSE:HLN) by 97.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 313,712 shares of the company’s stock after buying an additional 154,947 shares during the quarter. WCM Investment Management LLC’s holdings in Haleon were worth $2,983,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. GAMMA Investing LLC increased its stake in shares of Haleon by 49.7% in the third quarter. GAMMA Investing LLC now owns 15,043 shares of the company’s stock worth $159,000 after acquiring an additional 4,992 shares during the period. Atomi Financial Group Inc. grew its position in Haleon by 48.3% during the 3rd quarter. Atomi Financial Group Inc. now owns 22,518 shares of the company’s stock worth $238,000 after purchasing an additional 7,330 shares during the period. CWM LLC raised its stake in shares of Haleon by 13.6% during the 3rd quarter. CWM LLC now owns 24,978 shares of the company’s stock valued at $264,000 after buying an additional 2,996 shares during the last quarter. Ritholtz Wealth Management acquired a new position in shares of Haleon in the 3rd quarter valued at about $275,000. Finally, Procyon Advisors LLC boosted its stake in shares of Haleon by 1.7% in the third quarter. Procyon Advisors LLC now owns 162,911 shares of the company’s stock worth $1,724,000 after buying an additional 2,755 shares during the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Stock Performance

NYSE HLN opened at $9.55 on Monday. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon plc has a twelve month low of $7.89 and a twelve month high of $10.80. The stock has a 50-day moving average of $9.53 and a 200 day moving average of $9.79. The stock has a market capitalization of $43.21 billion, a price-to-earnings ratio of 28.07, a PEG ratio of 2.70 and a beta of 0.28.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on HLN shares. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Morgan Stanley cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $10.95.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.